[Study of apoplexy by home visits of the patients and their families].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Yano.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Recently, we developed long-acting microcapsules and microgranules of the LH-RH antagonist SB-75. In this study, we compared the inhibitory effects of a single injection of encapsulated and nonencapsulated LH-RH antagonist SB-75 on gonadotropin and testosterone secretion. The resulting serum SB-75 levels were also measured by RIA. Microgranules containing 4% of this antagonist in poly(DL-lactide-co-glycolide) were administered IM at two different doses (30 and 60 mg/rat) to male rats. Other groups of rats were injected SC with equivalent doses of nonencapsulated SB-75 (1.25 and 2.5 mg/rat). The administration of microgranules at a dose of 60 mg/rat produced a significant elevation of serum SB-75 until day 76, and serum testosterone and LH levels were suppressed below the detection limit of the RIA for a period of 70 days. An equivalent dose of nonencapsulated SB-75 acetate (2.5 mg/rat) produced a significant elevation of SB-75 levels for 20 days and decreased testosterone to castration values and LH levels for merely 21 days. In rats treated with 30 mg microgranules of SB-75 or an equivalent dose of SB-75 acetate (1.25 mg/rat), serum testosterone and LH were suppressed to a similar extent, but for only 2 weeks. In another study, the effect of a single SC injection of 1.25 mg/rat of antagonist SB-75 on pituitary LH-RH receptors was determined, 7 and 60 days after administration. SB-75 produced a significant (p < 0.01) downregulation of membrane receptors for LH-RH 7 days after administration.(ABSTRACT TRUNCATED AT 250 WORDS)
We report a 4-year-old Japanese girl with infantile sialic acid storage disease. She presented with failure to thrive, coarse facial features, hepatosplenomegaly, severe mental retardation and spastic quadriplegia. Electron microscopic examination of cultured skin fibroblasts revealed multiple vacuoles and inclusion material representing distended lysosomes, thus suggesting a lysosomal storage disorder. A high concentration of free sialic acid was present in the urine and cultured fibroblasts, but bound sialic acid was not increased. The activity of a variety of lysosomal enzymes was not diminished. The MRI findings included brain atrophy and a diffuse high signal in the cerebral white matter and low signal in the basal ganglia on T2-weighted images. To our knowledge, this is the first case of infantile sialic acid storage disease described in a non-Caucasian family.
Production of the F42 adhesive factor by porcine enterotoxigenic Escherichia coli (ETEC) grown on minimal solid medium was glucose-dependent. The addition of alanine and sodium acetate to this medium repressed the expression of this antigen whose production was also inhibited when the pH of the growing medium was lower than 7.4. The antigen was extracted from F42-positive ETEC grown in minimal liquid medium supplemented with 0.5% glucose. The cells were suspended in buffered 1 M NaCl and heated at 60 degrees C. The supernatant was then treated with ammonium sulphate and the resulting precipitate treated with deoxycholate followed by chromatography of the deoxycholate-soluble material on Sepharose-4B. The molecular weight of F42 purified antigen was near 31,000 daltons and its pI 3.2, as determined by polyacrylamide gel electrophoresis and isoelectric focusing, respectively. Immunoelectrophoretic studies showed that the purified F42 antigen presented a slight anodic migration and was recognized only by its homologous antiserum.
The effects of sedation by intravenous fentanyl on the rate-pressure product (pulse rate x systolic blood pressure/100), arterial oxygen saturation, electrocardiographic change, and serum cortisol concentration were studied during gastroduodenoscopy in 84 patients randomized to receive fentanyl or no intravenous sedative (controls). Fentanyl administration increased the tolerance of patients and attenuated the endoscopy-induced rise in rate-pressure product and serum cortisol concentration. Desaturation of arterial oxygen was minimal and there was no difference in arterial oxygen saturation between the fentanyl group and the control group. Therefore, fentanyl appears to be a favorable sedative for upper gastrointestinal endoscopy, since its administration increased the tolerance of patients and decreased cardiac oxygen consumption.
The incidence of fundic gland polyps was evaluated using a high-resolution videoendoscope. In 1388 upper gastrointestinal endoscopic studies, 26 cases of fundic gland polyps (1.9% of the studied cases) were found. None of these patients had evidence of familial adenomatous polyposis. Fifteen of these patients (58%) had a solitary polyp in the gastric body, most of which were small sessile polyps of less than 2 mm in diameter. The results of this study indicated that a small solitary fundic gland polyp is not a rare gastric lesion and that little relationship exists between these solitary fundic gland polyps and familial adenomatous polyposis.
It has been postulated that oxygen radical species are produced by ischemia-reperfusion in the brain and play a critical role in neuronal damage. Glutathione peroxidase (GSHPx), one of the antioxidative enzymes, detoxifies hydrogen peroxide, which is the source of a hydroxyl radical that reacts with polyunsaturated fatty acids of the cell membrane, resulting in cell death. The present study was undertaken to investigate the postischemic effect of exogenous GSHPx upon rats subjected to global forebrain ischemia and reperfusion. GSHPx or artificial cerebrospinal fluid (aCSF) as a vehicle for GSHPx was administered into the left cerebral ventricle 15 min after a 5-min 4-vessel occlusion. Neuronal damage and apoptosis were assessed 4 days after ischemic insult using cresyl violet stain and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method, respectively. Most pyramidal neurons in the hippocampal CA1 subfield were degenerated and their nuclei were stained by the TUNEL in both GSHPx- (80 and 200 units/kg) and aCSF-treated animals. Neurons in other subfields of the hippocampus and dentate gyrus survived. Our further attempt to improve the outcome with a higher dose of GSHPx was unsuccessful because all rats receiving 400 units/kg died soon after the intracerebroventricular injection due to respiratory insufficiency. We conclude that the postischemic treatment with GSHPx does not ameliorate the apoptotic neuronal death of hippocampal CA1 in this transient ischemia model under the conditions used here.
Prenatal exposure to bisphenol A (BPA), an estrogenic compound, has been shown to alter postnatal development at an environmentally relevant exposure level. To elucidate these low dose effects of preimplatation exposure to BPA, two-cell mouse embryos were cultured with 1 nM BPA. More embryos exposed to 1 nM BPA than controls reached the blastocyst stage. When the blastocysts with or without BPA exposure were transferred to uterine horns of pseudopregnant recipient mice not treated with BPA, the number of pups per litter and body weight at birth did not differ. At weaning on postnatal day 21, however, pups treated with 1 nM BPA during the preimplantation period were significantly heavier than controls. These findings suggest that BPA may not only affect early embryonic development even at low, environmentally relevant doses, but also may exert late effects on postnatal development.
Magnetic resonance imaging of 28 patients with radiological and/or histopathologically proved ossification of the ligamentum flavum (OLF) was reviewed. The locations of OLF were cervical (n = 4), thoracic (n = 22), and lumbar (n = 2). On T1- and T2-weighted images, OLF demonstrated low signal intensity. Areas of high or intermediate signal intensity within the OLF on T1-weighted images were observed in three cases and were interpreted to be due to fat infiltration. In six cases, high intensity areas in the spinal cord caused by compressing OLF were demonstrated on T2-weighted images. Gadolinium-diethylenetriamine pentaacetic acid, which was used in four cases, showed cord enhancement at the level of compression by OLF in three cases.
OBJECTIVE: Our goal was to determine the value and limitations of three-dimensional (3D) time-of-flight (TOF) MR angiography (MRA) for evaluating the patency of extracranial (EC)-intracranial (IC) bypasses. MATERIALS AND METHODS: The 3D TOF MRA was performed in 35 patients to evaluate their EC-IC bypasses (50 sites) at 1.5 T. Subtraction (rephased-dephased) MRA was performed to visualize slowly flowing blood in all patients. Angiographic images were obtained using maximum intensity projection from subtraction images and from rephased images. RESULTS: The patency of bypasses was confirmed at 22 sites and was suggestive at 17 other sites using MRA alone. The diagnostic value of subtraction MRA proved to be superior to that of rephased MRA, and the findings of subtraction MRA correlated relatively well with those of conventional angiography. Edited reprojection MR angiograms were helpful in visualizing collateral vessels without overlapping of vessels. CONCLUSION: Although there have been some problems with MRA so far, it is a useful imaging modality for following up patients who have undergone EC-IC bypass operations, in conjunction with clinical examination, transcranial Doppler sonography, and cerebral blood flow studies using single photon emission CT or PET.